Zydus Lifesciences バランスシートの健全性
財務の健全性 基準チェック /66
Zydus Lifesciencesの総株主資本は₹241.5B 、総負債は₹1.5Bで、負債比率は0.6%となります。総資産と総負債はそれぞれ₹314.5Bと₹72.9Bです。 Zydus Lifesciencesの EBIT は₹53.8Bで、利息カバレッジ比率-100.4です。現金および短期投資は₹25.0Bです。
主要情報
0.6%
負債資本比率
₹1.50b
負債
| インタレスト・カバレッジ・レシオ | -100.4x |
| 現金 | ₹24.95b |
| エクイティ | ₹241.55b |
| 負債合計 | ₹72.91b |
| 総資産 | ₹314.46b |
財務の健全性に関する最新情報
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Jun 10
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Dec 27We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt
Jul 15Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly
Feb 15Recent updates
Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Just Reported Earnings, And Analysts Cut Their Target Price
Nov 15Here's Why We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Is Well Worth Watching
Sep 14Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Business And Shares Still Trailing The Market
Aug 30Zydus Lifesciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Aug 14Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment
Aug 03Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
Jul 19Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 05Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
Jun 20Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Jun 10Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
May 25Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?
Mar 18Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%
Feb 28Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report
Feb 12Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Dec 27Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors
Dec 06With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case
Aug 23Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00
Jul 17We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt
Jul 15Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's
Jun 24Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00
Jun 10Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00
May 21Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly
Feb 15財務状況分析
短期負債: ZYDUSLIFEの 短期資産 ( ₹121.6B ) が 短期負債 ( ₹53.5B ) を超えています。
長期負債: ZYDUSLIFEの短期資産 ( ₹121.6B ) が 長期負債 ( ₹19.4B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: ZYDUSLIFE総負債よりも多くの現金を保有しています。
負債の削減: ZYDUSLIFEの負債対資本比率は、過去 5 年間で61.1%から0.6%に減少しました。
債務返済能力: ZYDUSLIFEの負債は 営業キャッシュフロー によって 十分にカバー されています ( 3062.5% )。
インタレストカバレッジ: ZYDUSLIFE支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。